baber/WOPTO huggingface dataset:
Patent AU-605977-B2 (AU)
Title: Method and apparatus for inhalation of treating gas and sampling of exhaled gas for quantitative analysis
Inventor: BOWE EDWIN A
IPC: A61M16/06
Filed: 1989-04-13
Granted: 1991-01-24
Abstract: A nasal cannulae and a method is described for insufflating a treating gas into one nostril of an unintubated, conscious, spontaneously breathing patient having local or regional anesthesia administered thereto or recovering from residual general anesthesia while accurately and reliably measuring at least one gaseous component of exhaled breath in the other nostril enabling adaption of treatment to the state of the body functions of the patient. The cannulae (10, 10', 40) includes a hollow body (12, 12', 43) divided by a wall member (18, 18', 52) into inhalation (20, 44) and exhalation (22, 54) manifolds which are connected to an oxygen flow regulating device (24) and breathing gas analyzer (26), respectively. Hollow nasal prongs of same (14, 16, 46) or different lengths (14', 15') and adapted to be received in corresponding nostrils communicate with the manifolds (20, 44, 22, 54), respectively. The wall member may be integrally molded (18) with the body (12) or a conventional cannulae may be modified by insertion of a wall member (48', 52).
Patent AU-603042-B2 (AU)
Title: Process for the production of o2,2' -anhydro-1-(beta-d- arabinofuranosyl)thymine
Inventor: MURTIASHAW CHARLES WILLIAM
IPC: A61K31/7064
Filed: 1989-07-11
Granted: 1990-11-01
Abstract: In the disclosed process, an O<2>,2 min anhydro-1-( beta -D-arabinofuranosyl)thymine is formed by condensing a 2-amino- beta -arabinofurano[1 min ,2 min :4,5,]-2-oxazoline with a compound of the formula <CHEM> wherein R1 is C1-C4 alkyl; X is halogen or OR2, wherein R2 is H, C1-C4 alkyl or phenyl; in the presence of a suitable solvent at about 0 DEG C to about 150 DEG C. Catalytic agents such as dimethylaminopyridine and triethylamine may also be added to accelerate the reaction. Protected intermediates of the anhydronucleosides and aminooxazolines are also disclosed.
Patent AU-701208-B2 (AU)
Title: Delivery of nucleic acid molecules to mucosal tissue
Inventor: WEINER DAVID B
IPC: C07K14/18
Filed: 1995-12-15
Granted: 1999-01-21
Abstract: Methods of inducing mucosal immunity in individuals against proteins and peptides are disclosed. The methods comprise the step of administering topically or by lavage into mucosal tissue selected from the group consisting of rectal, vaginal, urethral, sublingual and buccal, a nucleic acid molecule that comprises a nucleotide sequence that encodes a protein or peptide that comprises an epitope against which mucosal immunity is desired. The methods may be used to immunize and individual against a pathogen infection, hyperproliferative diseases or autoimmune diseases using nucleic acid molecules which encode proteins and peptides that share an epitope with a pathogen antigen or protein associated with cells involved in hyperproliferative diseases or autoimmune diseases, respectively.
Patent AU-575988-B2 (AU)
Title: Multiple strand elastic means
Inventor: POMPARELLI VINCENT
IPC: A61F13/494
Filed: 1985-08-16
Granted: 1988-08-11
Abstract: An elastic means is provided for a disposable diaper which elastic means has substantially parallel multiple strands of stretched elastic adhered between two layers of fabric by at least one sinusoidal adhesive line.
Patent AU-783395-B2 (AU)
Title: Herpes viruses for immune modulation
Inventor: COFFIN ROBERT STUART
IPC: A61K35/76
Filed: 2001-04-12
Granted: 2005-10-20
Abstract: Use of an attenuated herpes virus which lacks a functional vhs gene, or a functional equivalent thereof, in the manufacture of a medicament for use in a method of immunotherapy or vaccination comprising the infection of dentritic cells with said virus.
Patent AU-726577-B2 (AU)
Title: Heart valve replacement using flexible tubes
Inventor: COX JAMES L
IPC: A61F2/24
Filed: 1995-12-28
Granted: 2000-11-09
Abstract: This invention comprises a method of using tubular material (200) to replace a heart valve (118)(120)(162) during cardiac surgery. To create a replacement atrioventricular (mitral or tricuspid) valve (120)(160), the tube inlet is sutured to a valve annulus (121)(162) from which the native leaflets have been removed, and the tube outlet is sutured to papillary muscles (126)(128)(170) in the ventricle (112)(152). To create a semilunar (aortic or pulmonary) valve (118), the tube inlet is sutured to an annulus from which the native cusps have been removed, and the tube is either "tacked" at three points distally inside the artery, or sutured longitudinally along three lines; this allows the flaps of tissue between the three fixation points at the valve outlet to function as movable cusps. These approaches generate flow patterns that closely duplicate the flow patterns of native valves. A preferred tubular material (200) comprises submucosal tissue from the small intestine; this can be taken from the same patient who is undergoing the cardiac operation, to reduce antigenicity. Animal or cadaver intestinal tissue can also be used if properly treated, or a biocompatible synthetic tubular material can be used. This invention also discloses a properly treated intestinal tissue segment or synthetic tubular segment (500) suitable for implantation as a replacement heart valve, enclosed in a sealed sterile package (510). <IMAGE>
Patent AU-637991-B2 (AU)
Title: Novel piperazinyl derivatives
IPC: C07D231/54
Filed: 1989-12-22
Granted: 1993-06-17
Abstract: The invention relates to novel compounds of the formula: <CHEM>  wherein R<1>, R<2>, X and "Ar" are as defined in Claim 1; as well as pharmaceutically acceptable acid addition salts and stereo isomeres thereof. The compounds are described as having central sterotonin activity with preference for the serotonin 5-HT1A receptors, which indicates usefulness in the treatment of CNS disorders, including anxiety, depression and aggression, or in diseases related to cardiovascular, gastrointestinal and renal systems. Also methods of preparing said compounds and pharmaceutical compositions containing same are described.
Patent AU-527739-B2 (AU)
Title: 1,2,3,4,4a,9a-hexahydro-9,10-anthracene-dione,
Inventor: BOURSON LUCIEN
IPC: C07C49/76
Filed: 1979-06-28
Granted: 1983-03-17
Abstract: A new industrial product, namely 1,2,3,4,4a,9a-hexahydro-9,10-anthracene-dione, is disclosed together with a process for its preparation and its use in conventional alkali metal hydroxide cook or Kraft cook processes for the delignification of lignocellulose materials.
Patent AU-635518-B2 (AU)
Title: Assay for bone alkaline phospatase
IPC: G01N33/577
Filed: 1990-01-25
Granted: 1993-03-25
Abstract: A process for the determination of the presence or concentration of bone alkaline phosphatase (BAP) enzyme in a fluid which comprises:   (a) contacting a sample of the fluid with a first monoclonal antibody for BAP, wherein the first monoclonal antibody is bound to a solid carrier insoluble in the fluid, in order to form an insoluble complex between the first monoclonal antibody and BAP; (b) separating the fluid sample containing unreacted BAP from the insoluble complex of the first monoclonal antibody and BAP; (c) reacting a measured amount of a second, labeled monoclonal antibody to BAP, which antibody is soluble in the fluid, with the insoluble complex of the first monoclonal antibody and BAP, in order to form an insoluble complex of the first monoclonal antibody, BAP, and second, labeled antibody; (d) separating the solid carrier from unreacted second, labeled antibody; (e) measuring either the amount of second, labeled antibody associated with the solid carrier or the amount of unreacted second, labeled antibody; (f) relating the amount of measured second labeled antibody with the amount of labeled antibody measured for a control sample prepared in accordance with steps (a) thru (e), said control sample being known to be free of BAP, to determine the presence of BAP in said fluid sample, or relating the measured amount of labeled antibody for the fluid sample with the amount of labeled antibody measured for samples containing a known amount of BAP prepared in accordance with steps (a) thru (e) to determine the concentration of BAP in the fluid sample; wherein both monoclonal antibodies used are highly specific for BAP, especially in the presence of LAP.
Patent AU-671166-B2 (AU)
Title: A process for obtaining a range of colours of the visible spectrum using electrolysis on anodized aluminium
Inventor: MARTINEZ DIONISIO RODRIGUEZ
IPC: C25D11/04
Filed: 1993-12-31
Granted: 1996-08-15
Abstract: The process starts with the three classic phases, namely a first phase to form an anodic film, a second phase to modify the barrier film and a third phase to deposit metallic particles on the barrier film, its characteristics lying in that in the first phase, namely formation of the anodic film, a thickness in excess of 0.3  mu m is established, that the second phase, namely the electrolytic modification of the barrier film, is carried out in a low dissolving power electrolyte, applying a low voltage and a low current density, and that the third phase is carried out by a slight electrolytic deposition of metallic particles in order to increase internal reflections under the said deposit. In particular, the average voltage applied in the electrolytic modification of the barrier film is below 5 volts of a complex alternating current, and the average density of the current applied is less than 200 mA/dm<2> of the said complex alternating current.
Patent AU-699304-B2 (AU)
Title: Body adhering sanitary protection products
Inventor: LICHSTEIN BERNARD M
IPC: A61F13/15
Filed: 1996-04-23
Granted: 1998-12-03
Abstract: Provided are absorbent sanitary protection products for direct attachment to the skin and hair of a user. The products comprise an absorbent core, a barrier layer coupled to one side of the core and a pressure sensitive adhesive layer on the side of the core that faces the body of a user. The pressure sensitive adhesive has sufficient adhesive strength to enable the product to adhere securely to the skin and hair of the user and yet to be removed without pain or trauma. Products described include those that are restricted to covering and adhering to the perineal area as well as those having ancillary structures to attach to body structures beyond the perineal area. Additionally disclosed is a packaged arrangement of the products of the invention for which little or no release paper is required.
Patent AU-712238-B2 (AU)
Title: Extensible model network representation system for process planning
Inventor: KENNEDY BRIAN M
IPC: G06Q10/06
Filed: 1996-06-14
Granted: 1999-11-04
Abstract: A computer software system for modeling a process capability on a computer is provided. The computer software system comprises an operation model type for defining a plurality of operation models (33, 36, 44, 52 and 57). Each operation model represents an activity that can be performed by a process. A resource model type is for defining a plurality of resource models (32, 38, 40, 46, 48, 54, 56 and 58). Each resource model represents capacity available for use in performing an activity and rules for allocating capacity to the activity. A buffer model type is for defining a plurality of buffer models (34, 42, 50, and 60). Each buffer model represents rules for controlling a flow of material between activities. The operation model type, buffer model type, and resource model type each comprise a plurality of fields defining attributes that include a plurality of extension selector fields. Defined operation models, buffer models, and resource models are stored as nodes in an interrelated process network model.
Patent AU-640672-B2 (AU)
Title: Graft copolymers and a process for their preparation
IPC: C08G81/00
Filed: 1990-07-17
Granted: 1993-09-02
Abstract: Polyamide-grafted poly(glutarimide) ionomers can form tough, clear thermoplastic materials having resistance to stress-whitening and attractive optical properties. The ionomers may be provided in blends with ungrafted polyamide and poly(glutarimide) in amounts of above 5% by weight of ionomer by a process wherein the polyamide and poly(glutarimide) are reacted at elevated temperature in the presence of a catalytic amount of a base.
Patent AU-645258-B2 (AU)
Title: Radionuclide metal chelates for the radiolabeling of proteins
Inventor: GUSTAVSON LINDA M
IPC: C07D309/08
Filed: 1990-06-15
Granted: 1994-01-13
Abstract: Chelating compounds of specified structure are useful for radiolabeling targeting proteins such as antibodies. The radiolabeled antibodies, or catabolites thereof, demonstrate improved biodistribution properties, including reduced localization within the intestines.
Patent AU-609703-B2 (AU)
Title: Thermally adoptive polymers and prepolymers and methods of making them
Inventor: PARKER JOHN A
IPC: C07D493/08
Filed: 1986-08-26
Granted: 1991-05-09
Abstract: Reaction of an aromatic dianhydride with a polycyclic aromatic primary diamine at a controlled reaction rate yields a diamic acid dianhydride oligomer. The oligomer may be a precursor for an imide foam which forms at a low temperature, has outstanding physical characteristics, and is extremely heat resistant. The diamic acid moiety may be converted to diimide, and other modifications of the oligomer are disclosed. Other derivatives of the oligomeres are also disclosed.
Patent AU-647046-B2 (AU)
Title: Plastics articles with compatibilized barrier layers
Inventor: ILENDA CASMIR STANISLAUS
IPC: C08L57/00
Filed: 1990-09-24
Granted: 1994-03-17
Abstract: Polyolefin - acrylic graft copolymers capable of compatibilising melt processible polyolefin and gas barrier resins are used therewith as adhesives in multilayer composites or as a third component therewith in monolithic articles so as to produce packaging materials and articles, such as films and bottles for use especially in food and drinks packaging.
Patent AU-635967-B2 (AU)
Title: Process for preparation of syndiotactic vinyl aromatic polymers
IPC: C08F4/42
Filed: 1990-09-28
Granted: 1993-04-08
Abstract: A process for preparing syndiotactic vinyl aromatic polymers comprising contacting one or more aromatic monomers under polymerization conditions with a catalyst corresponding to the formula:  [CpmMXnX min p]<+>A<->  wherein: Cp is a single  eta <5>-cyclopentadienyl or  eta <5>-substituted cyclopentadienyl group; M is a metal of Group 3, 4, 5, 6, 8, 9, 10 or the Lanthanide Series of the Periodic Table; X each occurrence is an inert anionic lignd, with the proviso that at least one X is R;  X min  is an inert, neutral, donor ligand; R is hydrocarbyl, silyl, a combination thereof or a substituted derivative thereof having up to 20 carbon, silicon or carbon and silicon atoms;  m and p are independently 0 or 1;  n is an integer greater than or equal to 1;  the sum of m and n is equal to the valence of M; and A<-> is a noncoordinating, compatible anion of a Bronsted acid salt.
Patent AU-685792-B2 (AU)
Title: Attachment member setting tool and method for setting the attachment member
Inventor: SCHMIDLE JOSEF
IPC: B25C1/18
Filed: 1994-06-07
Granted: 1998-01-29
Abstract: Fastening elements (28) which serve to fasten insulating panels (30) to building components (31) are fixed by means of setting tools. With the aid of a connecting region (26a), which produces a frictional force, on a guide tube (25) of the setting tool, it is possible to carry out a setting check once the setting operation is completed. For this purpose, the frictional force between the guide tube (25) and the interior of the hollow shaft (28b) of the fastening element (28) is greater than the frictional force between hollow shaft (28b) and insulating panels (30). <IMAGE>
Patent AU-691128-B2 (AU)
Title: Apparatus using light guides and filters to create visual animation effects
Inventor: JUCHYMENKO VICTOR Y
IPC: G02B6/04
Filed: 1994-06-22
Granted: 1998-05-07
Abstract: Light processing apparatus creates a number of visual effects which simulate movement with light from a light source. A multiplicity of flexible fibre optic light guides having optically finished input and output ends are grouped into groups, with each group being assigned to create a particular effect. The input ends of each group of light guides are placed in adjacent receptor zones of pre-selected geometry, and the output ends of each group of light guides are located on an effects surface in a pre-selected pattern. Light from the light source is filtered by a colour changer having a plurality of discrete moveable coloured filter zones shaped to correlate with the receptor zones, and is then received by the input ends of the light guides and distributed to the ouptut ends of the light guides. The colour changer may be a rotatable colour wheel filter, an endless band filter or a cylindrical filter.
Patent AU-782481-B2 (AU)
Title: Monomeric protein of the TGF-beta family
Inventor: HOTTEN GERTRUD
IPC: C07K14/475
Filed: 2000-08-04
Granted: 2005-08-04
Abstract: The present invention is concerned with proteins selected from the members of the TGF- beta  superfamily, which are monomeric due to substitution or deletion of a cysteine which is responsible for dimer formation. <??>The invention is also concerned with nucleic acids, encoding such monomeric proteins, vectors or host cells containing the nucleic acids as well as with pharmaceutical compositions comprising the proteins or nucleic acids encoding the proteins. The pharmaceutical compositions can be applied advantageously for all indications for which the respective dimeric proteins are useful.
Patent AU-602513-B2 (AU)
Title: Digital phase locked loop stabilization circuitry using a secondary digital phase locked loop
Inventor: DEMMER WALTER HEINRICH
IPC: H03L7/22
Filed: 1987-03-23
Granted: 1990-10-18
Abstract: As used in a digital television receiver, the invention is associated with a first phase locked loop which develops a sampling clock signal that is locked to the horizontal line synchronizing signal components of a composite video signal. A second digital phase locked loop is clocked by the sampling clock signal and develops a digital signal that is phase locked to the color burst signal. This digital signal is used as a regenerated color subcarrier signal to synchronously demodulate the chrominance components of the composite video signals into I and Q color difference signals. To compensate for frequency instability in the regenerated subcarrier signal caused by frequency instabilities in the line-locked clock signal, a third digital phase locked loop (300) develops an output signal which is phase locked to a reference signal generated by a crystal controlled oscillator (310). Control signals (C') from the third phase locked loop are applied (328) to the second phase locked loop to substantially compensate for frequency instabilities in the regenerated subcarrier signal that are induced by the clock signals.
Patent AU-593902-B2 (AU)
Title: Hydroxyphenyl and hydroxyphenoxy alkanoic acid iodopropargyl esters
Inventor: STAIGER GERHARD
IPC: C07C255/57
Filed: 1987-04-24
Granted: 1990-02-22
Abstract: The invention concerns compounds having the formula <CHEM> wherein R<1>, R<2>, R<3>, R<4> can mean identical or different radicals in any desired position on the benzene ring, namely fluoro, chloro, bromo, iodo, cyano, or nitro radicals, alkyl radicals having from 1 to 4 carbon atoms, cyclo alkyl radicals having from 3 to 7 carbon atoms, phenyl, phenylsulfonyl and phenoxy radicals and hydrogen;  n can mean a number with the value of 1 or 2 and  x can mean CH2, and where n = 1, O-CH2 as well. The named compounds show efficiency as fungicides.
Patent AU-718869-B2 (AU)
Title: Stent for improved transluminal deployment
Inventor: LASHINSKI ROBERT
IPC: A61F2/90
Filed: 1996-11-25
Granted: 2000-04-20
Abstract: The disclosure relates to a stent and method for manufacturing a stent (21) comprising an expandable, generally tubular body portion in which one or both ends (22, 23) of the stent are provided with a generally rounded, smooth radiused portion that forms a bulbous protrusion (20) out of the plane of the circumference of the stent. The design of the stent increases the profile of the end of the stent and decreases the risk of injury or vessel dissection during stent deployment. <IMAGE>
Patent AU-740986-B2 (AU)
Title: Integrated optical circuit
Inventor: KOOPS HANS WILFRIED PETER
IPC: G02B6/122
Filed: 1998-04-29
Granted: 2001-11-22
Abstract: An integrated optical circuit is described. The optical circuit includes a silicon substrate and waveguides disposed thereon, at least one photonic crystal is provided as a waveguide.
Patent AU-739778-B2 (AU)
Title: Process for the removal of heavy metals
Inventor: VILLA MARCO
IPC: C07B63/02
Filed: 1998-05-04
Granted: 2001-10-18
Abstract: A method for the removal of heavy metals from solutions of organic compounds by treatment with cysteine or with an N-acylcysteine is described. Organic compounds with a content of heavy metal, for example palladium, particularly low and suitable for the preparation of compounds with pharmacologic activity can be isolated from the resultant solutions.
Patent AU-712445-B2 (AU)
Title: Cartilage/bone inducing materials for reparation
Inventor: SHIMURA TAKESADA
IPC: A61K38/18
Filed: 1996-11-14
Granted: 1999-11-04
Abstract: A cartilage and bone morphogenetic repairing material which contains a bone morphogenetic protein and a polyoxyethylene-p-olyoxypropylene glycol. In particular, it is preferable that a molecular weight of a polypropylene glycol, i.e., a component of said polyoxyethylene-polyoxypropylene glycol, being in the range of about 1,500-4,000 and a weight ratio of ethylene oxide being in the range of 40-80%/molecule, and a concentration of said polyoxyethylene-polyoxypropylene glycol in an aqueous solution being about 10-50%. It may be applied in a cartilage and bone morphogenetic method requiring no surgical operation and which comprises a bone morphogenetic protein and a carrier having a high bio-absorption, a good affinity to the bone morphogenetic protein and capable of temperature dependent gel-sol reversible transition. It is convenient to apply locally to the site of bone fracture or bone defect with efficient treatment effect. <IMAGE>
Patent AU-591857-B2 (AU)
Title: Gangway for a railway car passageway
Inventor: KUKER WOLFGANG
IPC: B61D17/20
Filed: 1987-08-21
Granted: 1989-12-14
Abstract: A gangway is provided between two railway cars or units of railway cars that are pivoted to one another, and that forms a continuous, stepless passage for all travel motions. The entire gangway is designed as a unit that is held in the central position to each of the ends of the cars facing one another with the ability to shift lengthwise, by a centering device, and is supported and guided on bridge bearings, and is mounted to be able to pivot around its vertical axis and also to be able to tip out of the horizontal plane. The bridge area of the gangway consists of a number of rigid rails placed parallel to one another at prescribed distances and able to move lengthwise, which are enclosed and guided at both ends in supporting profiles that are mounted and guided on the bridge bearings associated with them.
Patent AU-591333-B2 (AU)
Title: Polyols
Inventor: POWELL RICHARD LLEWELLYN
IPC: C07C43/13
Filed: 1987-09-07
Granted: 1989-11-30
Abstract: Fluorine-containing polyols obtained by the free radical addition of a fluoro-olefin having the general formula: <CHEM> wherein Y represents F and Z represents Cl or F(CF2)n- wherein n is an integer from 0 to 10 or Y and Z together form a -(CF2)m- chain wherein m represents an integer from 2 to 4 to a polyol wherein each hydroxyl group is directly attached to a group of the formula:  -(CH2)pO -      (2) wherein p is an integer of at least 4. a